DELCATH SYSTEMS, INC. Logo

DELCATH SYSTEMS, INC.

Interventional oncology company treating liver cancers with targeted chemotherapy.

DCTH | US

Overview

Corporate Details

ISIN(s):
US24661P8077
LEI:
Country:
United States of America
Address:
566 QUEENSBURY AVENUE, 12804 QUEENSBURY

Description

Delcath Systems, Inc. is a commercial-stage interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company develops and commercializes proprietary products for percutaneous hepatic perfusion (PHP), a minimally-invasive procedure designed to administer high-dose chemotherapy directly to the liver while controlling systemic exposure. Its flagship product in the United States is the HEPZATO KIT™ (melphalan/hepatic delivery system), an FDA-approved drug/device combination product for treating adult patients with metastatic uveal melanoma. In Europe, the company markets the CHEMOSAT® Hepatic Delivery System, a medical device for the same procedure.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2013-11-19 00:08
PRIMARY DOCUMENT
English 5.9 KB
2013-11-19 00:04
PRIMARY DOCUMENT
English 6.0 KB
2013-11-19 00:01
PRIMARY DOCUMENT
English 6.0 KB
2013-11-18 23:26
8-K
English 8.4 KB
2013-11-12 22:05
DELCATH SYSTEMS FORM 8-K
English 45.3 KB
2013-11-07 22:31
FORM 8-K
English 38.8 KB
2013-11-06 22:47
DELCATH SYSTEMS INC 10-Q 9-30-2013
English 976.7 KB
2013-11-01 22:03
PRIMARY DOCUMENT
English 5.6 KB
2013-11-01 15:41
SABBY 13G DCTH 11.1.13
English 11.0 KB
2013-10-31 21:01
FORM 8-K
English 8.4 KB
2013-10-28 21:07
FORM 8-K
English 132.1 KB
2013-10-23 19:38
PROSPECTUS SUPPLEMENT
English 218.3 KB
2013-10-23 14:35
8-K
English 117.4 KB
2013-10-17 17:45
FORM 8-K
English 920.1 KB
2013-10-16 22:05
8-K
English 7.5 KB

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cyfuse Biomedical K.K. Logo
Develops scaffold-free bio 3D printing technology for tissue and organ fabrication.
Japan
4892
CYTOKINETICS INC Logo
A late-stage biopharma developing drugs for diseases of impaired muscle function.
United States of America
CYTK
CytomX Therapeutics, Inc. Logo
Clinical-stage oncology company developing conditionally activated biologics.
United States of America
CTMX
Cytori Cell Research Institute,Inc. Logo
Develops cell therapy medical devices using a patient's own adipose tissue.
Japan
3750
Daebonglsco.,Ltd Logo
Develops and supplies raw materials for the pharmaceutical, cosmetic, and food industries.
South Korea
078140
DaehanPharmaceutical Logo
Researches, develops, and manufactures human/animal pharma and bio-pharmaceuticals.
South Korea
023910
DAE HWA PHARM CO., LTD Logo
Pharmaceutical firm developing drugs with proprietary drug delivery system technologies.
South Korea
067080
Daesung Microbiological Labs. Co. Ltd Logo
Develops, manufactures, and distributes animal pharmaceuticals and vaccines.
South Korea
036480
DAEWON PHARMACEUTICAL CO.,LTD Logo
Develops and manufactures prescription drugs and finished pharmaceutical products.
South Korea
003220
DAEWOONG CO.,LTD Logo
A holding company in the biotech and healthcare sectors developing pharmaceuticals.
South Korea
003090

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.